Morphine for management of refractory dyspnoea

BMJ

Volumn 327, Issue 7426, 2003, Pages 1288-1289

  Currow, D C ^a   Abernethy, Amy P ^a   Frith, Peter ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ASSISTED VENTILATION; BIOAVAILABILITY; BREATHING RATE; CAPILLARY BLOOD; CAPNOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DYSPNEA; HUMAN; LETTER; LUNG ALVEOLUS HYPOVENTILATION; LUNG FUNCTION; MEDICAL ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SAMPLING; SPIROMETRY; TIDAL VOLUME;

ANALGESICS, OPIOID; CHRONIC DISEASE; DYSPNEA; HUMANS; MORPHINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0344393477     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.327.7426.1288-c     Document Type: Letter

References (4)

1. McKenzie DK, Frith PA, Burdon JG, Town GI. The CPODX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust 2003; 178(suppl):S7–39.
2. Canadian Thoracic Society. Executive summary. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 2003; 10(suppl): SA.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD. Updated 2003. http://www.goldcopd.com/ (accessed 16 Nov 2003).
4. Heyse-Moore L, Beynon T, Ross V. Does spirometry predict dyspnoea in advanced cancer? Pall Med 2000; 14: 189–95.